Decreasing mortality rate in early pneumonia following hematopoietic stem cell transplantation

Scandinavian Journal of Infectious Diseases

Volumn 38, Issue 11-12, 2006, Pages 970-976

  Forslöw, Ulrica ^a   Mattsson, Jonas ^a   Ringden, Olle ^a   Klominek, Julius ^a   Remberger, Mats ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; BUSULFAN; CIPROFLOXACIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FOSCARNET; GANCICLOVIR; GRANULOCYTE COLONY STIMULATING FACTOR; HLA A ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN; IMMUNOGLOBULIN; METHOTREXATE; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BACTEREMIA; CHILD; COMBINATION CHEMOTHERAPY; CYTOMEGALOVIRUS INFECTION; FEMALE; FEVER; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORTALITY; MULTIVARIATE ANALYSIS; NONHUMAN; PNEUMONIA; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDY; RISK FACTOR; T CELL DEPLETION; VIRUS PNEUMONIA; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; FEMALE; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITALS, UNIVERSITY; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PNEUMONIA; RETROSPECTIVE STUDIES; RISK FACTORS; SWEDEN; TRANSPLANTATION CONDITIONING;

EID: 33845305510     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540600786481     Document Type: Article

References (25)

1. Chen, CS and Boeckh, M and Seidel, K and Clark, JG and Kansu, E and Madtes, DK and (2003) Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantation Bone Marrow Transplantation, 32, pp. 515.
2. Slavin, S and Nagler, A and Naparstek, E and Kapelushnik, Y and Aker, M and Cividalli, G and (1998) Non-myeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and non-malignant haematological diseases Blood, 91, pp. 756.
3. Hentschke, P and Barkholt, L and Uzunel, M and Mattsson, J and Wersäll, P and Pisa, P and (2003) Low-intensity conditioning and hematopoietic stem cell transplantation in patients with renal and colon carcinoma Bone Marrow Transplantation, 31, pp. 253.
4. Ringdén, O and Pihlstedt, P and Markling, L and Aschan, J and Bäryd, I and Ljungman, P and (1991) Prevention of graft-versus-host disease with T-cell depletion or cyclosporin and methotrexate. A randomized trial in adult leukaemic marrow recipients Bone Marrow Transplantation., 7, pp. 221.
5. Storb, R and Deeg, H and Whitehead, J and Appelbaum, F and Beatty, P and Bensinger, W and (1986) Methotrexate and cyclosporin compared with cyclosporin alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukaemia New England Journal of Medicine, 314, pp. 729.
6. Sparrelid, E and Hägglund, H and Remberger, M and Ringdén, O and Lönnqvist, B and Ljungman, P and (1998) Bacteraemia during the aplastic phase after allogeneic bone marrow transplantation is associated with early death from invasive fungal infection Bone Marrow Transplantation., 22, pp. 795.
7. Ljungman, P and Lore, K and Aschan, J and Klaesson, S and Lewensohn-Fuchs, I and Lönnqvist, B and (1996) Use of a semi-quantitative PCR for cytomegalovirus DNA as a basis for pre-emptive antiviral therapy in allogeneic bone marrow transplant patients Bone Marrow Transplantation., 17, pp. 583.
8. Ljungman, P and Aschan, J and Lewensohn-Fuchs, I and Carlens, S and Larsson, K and Lönnqvist, B and (1998) Results of different strategies for reducing cytomegalovirus-associated mortality in allogeneic stem cell transplant recipients Transplantation, 66, pp. 1330.
9. Ljungman, P and Griffiths, P and Paya, C. (2002) Definitions of cytomegalovirus infection and disease in transplant recipients Clinical Infectious Diseases, 34, pp. 1094.
10. Einsele, H and Ehninger, G and Hebart, H and Wittkowski, KM and Schuler, U and Jahn, G and (1995) Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side-effects of antiviral therapy after bone marrow transplantation.[see comment] Blood, 86, pp. 2815.
11. Dettenkofer, M and Wenzler-Rottele, S and Babikir, R and Bertz, H and Ebner, W and Meyer, E and (2005) Surveillance of nosocomial sepsis and pneumonia in patients with bone marrow or peripheral blood stem cell transplant: A multicentre project Clin Infect Dis, 40, pp. 926.
12. Walter, EA and Bowden, RA. (1995) Infection in the bone marrow transplant recipient Infectious Disease Clinics of North America, 9, pp. 823.
13. Martino, R and Manteiga, R and Sanchez, I and Brunet, S and Sureda, A and Badell, I and (1995) Viridans streptococcal shock syndrome during bone marrow transplantation Acta Haematologica, 94, pp. 69.
14. Morris, JG, Jr and Shay, DK and Hebden, JN and McCarter, RJ, Jr and Perdue, BE and Jarvis, W and (1995) Enterococci resistant to multiple antimicrobial agents, including vancomycin. Establishment of endemicity in a university medical centre Annals of Internal Medicine, 123, pp. 250.
15. Winston, DJ and Maziarz, RT and Chandrasekar, PH and Lazarus, HM and Goldman, M and Blumer, JL and (2003) Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicentre, randomized trial [see comment] Annals of Internal Medicine., 138, pp. 705.
16. Marmont, AM and Gale, RP and Sobocinski, K and Ash, RC and van Bekkum, D and Champlin, RE and (1991) T-cell depletion of HLA-identical transplants in leukaemia Blood, 78, pp. 2120.
17. Castagena, E and Cappelli, B and Erba, D and Rabagliati, A and Lanino, E and Dini, G. (2004) Cytomegalovirus infection after bone marrow transplantation in children Hum Immunology, 65, pp. 416.
18. Grob J, Grundy J, Prentice H. Interstitial pneumonitis in recipients of HLA-matched T-depleted BMT: Apparent effect of received lung TBI-dose. Bone Marrow Transplantation 1986:49(Suppl1).
19. Della Volpe, A and Ferreri, AJ and Annaloro, C and Mangili, P and Rosso, A and Calandrino, R and (2002) Lethal pulmonary complications significantly correlate with individually assessed mean lung dose in patients with haematological malignancies treated with total body irradiation Int J Radiat Oncol Biol Phys, 52, pp. 483.
20. Savani, BM and Montero, A and Wu, C and Nlonda, N and Read, E and Dunbar, C and (2005) Prediction and prevention of transplant-related mortality from pulmonary causes after total body irradiation and allogeneic stem cell transplantation Biol Blood Marrow Transplant, 11, pp. 223.
21. Ljungman, P and Brand, R and Einsele, H and Frassoni, F and Niederwieser, D and Cordonnier, C. (2003) Donor CMV serological status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: An EBMT megafile analysis Blood, 102, pp. 4255.
22. Broers, AE and van Der Holt, R and van Esser, JW and Gratama, JW and Henzen-Logmans, S and Kuenen-Boumeester, V and (2000) Increased transplant-related mortality and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation Blood, 95, pp. 240.
23. Sharma, S and Nadrous, HF and Peters, SG and Tefferi, A and Litzow, MR and Aubry, MC and Afessa, B. (2005) Pulmonary complications in adult blood and marrow transplant recipients: Autopsy findings Chest, 128, pp. 1385.
24. Raboni, SM and Nogueire, MB and Tsuchiya, LR and Takahashi, GA and Pereira, LA and Pasquini, R and Siqueira, MM. (2003) Respiratory tract viral infections in bone marrow transplant patients Transplantation, 76, pp. 142.
25. Nusair, S and Breuer, R and Shapira, MY and Berkman, N and Or, R. (2004) Low incidence of pulmonary complications following non-myeloablative stem cell transplantation Eur Respir J, 23, pp. 440.